| Baseline Characteristics of 22 patients |
| Age(years) |
67.0 ± 10.0 |
| Gender(Male/Female) |
59%(13/9) |
| History of hemo-dialysis(momths) |
59.5 ± 31.6 |
| Etiology of end-stage renal disease |
|
| Diabetes Mellitus |
10(45%) |
| Glomerulonephritis |
7(32%) |
| Renal Sclerosis |
4(18%) |
| Polycystic Kidney |
1(5%) |
| ECG Findngs |
| LVH |
7(32%) |
| CRBBB |
2(22%) |
| WNL |
13(59%) |
| Echocardiogram Findings |
|
| IVS |
13.5 ± 1.3mm |
| PW |
12.8 ± 1.3mm |
| EF |
68.8 ± 6.2% |
| ABI Findings |
| Abnormal(ABI<0.9) |
4(18%) |
| Normal |
19(86.4%) |
| Antihyperensive Drugs(number of patients) |
| 6 drugs |
3(14%) |
| 5 drugs |
5(23%) |
| 4 drugs |
9(41%) |
| 3 drugs |
5(23%) |
| 2 drugs |
1(5%) |
| Mean dose of olmesaltan |
30.7 ± 5.4mg |
| Calcium channel blolers(number of patients) |
20(91%) |
| Beta blokers |
17(77%) |
| Alpha blokers |
13(59%) |
| Methyldopa |
8(36%) |
| Clonidine |
4(18%) |
| Others |
6(27%) |
